给大家打气,这是黎明前的黑暗。

这篇文章的小编说: “今天小编看新闻得知了一个好消息,也算是给黑暗中的大家一丝曙光了吧!”


上个月月底,根据央视新闻的报道,中国首款抗新冠特效药已经获批上市。
央视新闻和其他媒体也是在这几天,对这款药物进行了非常详尽的报道。

这款药物叫做:“安巴韦单抗/罗米司韦单抗联合疗法”
它由两种抗体组成,目前在全球四大洲的6个国家、110个医疗机构,都已经做过了三期的临床试验。
实验结果证明:这款药物可以将住院率和死亡率下降80%。

这款药物是从2021年4月在多个疫情严重地区紧急批准后开始使用的。
在国内的多轮疫情当中,它目前已救治800余名患者,有效性已初步得到了验证。
 

Omicron cannot escape body's second-line defense


A key part of the immune system's second-line defense - its T cells - are highly effective at recognizing and attacking the Omicron variant, thereby preventing most infections from progressing to critical illness, a new study shows.

Omicron's mutations help it escape from antibodies, the body's first line of defense against infection. Researchers have speculated that other components of the immune response would still target Omicron, but there has been no proof until now.


In test tube experiments, researchers in South Africa exposed copies of the virus to T cells from volunteers who had received vaccines from Johnson & Johnson (JNJ.N) or Pfizer(PFE.N)/BioNTech(22UAy.DE) or who had not been vaccinated but had developed their own T cells after infection with an earlier version of the coronavirus.

"Despite Omicron's extensive mutations and reduced susceptibility to neutralizing antibodies, the majority of T cell response, induced by vaccination or natural infection, cross-recognizes the variant," the researchers reported on Tuesday on medRxiv ahead of peer review.


别怕,第二个研究也说疫苗的第二层防线T细胞还在起作用,这是两个分别的研究。应该是好消息,可以防重症。
如果不得重症,感染应该是好消息。
 
真要是开放了,这飞机上得是个什么光景啊,还不得挤爆了。恐怕就算开放了,也玩儿不好。
 
必须挺住啊,好几年没见我妈了。还等着是我妈包的饺子呢!
同感,三年没回国了,以前可是每年回去,吃饭喝酒打牌,真放松
 


别怕,第二个研究也说疫苗的第二层防线T细胞还在起作用,这是两个分别的研究。应该是好消息,可以防重症。
如果不得重症,感染应该是好消息。
T 如果真管用
为啥还要第三第四针?
 
后退
顶部
首页 论坛
消息
我的